Showing results (61-70 of 263) with videos related to
Sort By:
Pageof 27
Drug Design, Development and Therapy|March 4, 2016
Potential for bispecific T-cell engagers: role of blinatumomab in acute lymphoblastic leukemiaCaroline Le Jeune, Xavier ThomasExpert Opinion on Pharmacotherapy|November 1, 2016
Treating adults with acute lymphocytic leukemia: new pharmacotherapy optionsXavier Thomas, Caroline Le JeuneCurrent Treatment Options in Oncology|February 2, 2017
Treatment of Elderly Patients With Acute Myeloid LeukemiaXavier Thomas, Caroline Le JeuneHematology (Amsterdam, Netherlands)|August 13, 2003
Prognostic factors in adult acute lymphoblastic leukemiaXavier Thomas, Quoc-Hung LeMediterranean Journal of Hematology and Infectious Diseases|March 16, 2017
Hydroxycarbamine: from an Old Drug Used in Malignant Hemopathies to a Current Standard in Sickle Cell DiseaseGiovanna Cannas, Solène Poutrel, Xavier ThomasExpert Opinion on Drug Discovery|May 16, 2017
The preclinical discovery of vosaroxin for the treatment of acute myeloid leukemiaEtienne Paubelle, Florence Zylbersztejn, Xavier ThomasOncology and Therapy|March 30, 2024
Is There any Relationship Between the Repeated Complications of Sickle Cell Disease and the Potential Development of Acute Leukemia?Giovanna Cannas, Mohamed Elhamri, Xavier ThomasBulletin Du Cancer|August 26, 2011
[Novel conventional therapies in onco-hemathology]Frédéric Baleydier, Carine Domenech, Xavier ThomasExpert Review of Hematology|April 21, 2020
Emerging pharmacotherapies for elderly acute myeloid leukemia patientsXavier Thomas, Mohamed Elhamri, Maël HeibligBulletin Du Cancer|August 30, 2008
[Adult acute lymphoblastic leukemia with central nervous system involvement: an overview]Xavier Thomas, Laura Pavan, Quoc-Hung LePageof 27